The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men

Journal of Immigrant and Minority Health

Volumn 13, Issue 1, 2011, Pages 36-41

  Elson, Joshua K ^a   Beebe Dimmer, Jennifer L ^b   Morgenstern, Hal ^a,c   Chilkuri, Mahdavi ^d   Blanchard, John ^e   Lentsch, Alex B ^e  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d South East Regional Health Authority ^*  (Jamaica)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

African descent; Chemokine receptors; DARC; Epidemiology; Erythrocytes; Prostate cancer

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR; DARC PROTEIN, HUMAN;

AFRICA; AGED; ARTICLE; BLOOD; BLOOD GROUP DUFFY SYSTEM; CASE CONTROL STUDY; ERYTHROCYTE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HUMAN; JAMAICA; MALE; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; RISK ASSESSMENT; STATISTICAL MODEL;

AFRICA; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAMAICA; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RISK ASSESSMENT;

EID: 79551497653     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-010-9330-z     Document Type: Article

References (19)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray M Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. A Hsing S Devesa 2001 Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev 23 3 13 1:STN:280:DC%2BD3Mrkt1Skuw%3D%3D 11588851
3. D Bruner D Moore A Parlanti J Dorgan P Engstrom 2003 Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis Int J Cancer 107 797 803 1:CAS:528:DC%2BD3sXovVKjs74%3D 10.1002/ijc.11466 14566830 (Pubitemid 37339734)
4. A Ghafoor A Jemal V Cokkinides C Cardinez T Murray A Samuels MJ Thun 2002 Cancer statistics in African Americans Cancer J Clin 52 322 325 10.3322/canjclin.52.6.326
5. F Glover Jr D Coffey L Douglas M Cadogan H Russell T Tulloch T Baker R Wan P Walsh 1998 The epidemiology of prostate cancer in Jamaica J Urol 159 1984 1986 10.1016/S0022-5347(01)63220-8 9598503
6. H Shen R Schuster K Stringer S Waltz A Lentsch 2006 The duffy antigen/receptor for chemokines (DARC) regulates prostate cancer growth FASEB J 20 59 64 1:CAS:528:DC%2BD28XislSmsg%3D%3D 10.1096/fj.05-4764com 16394268 (Pubitemid 43100476)
7. T Hadley S Peiper 1997 From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen Blood 89 3077 3091 1:CAS:528:DyaK2sXivVOns70%3D 9129009
8. M Szabo K Soo A Zlotnik T Schall 1995 Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor J Biol Chem 270 25348 25351 1:CAS:528:DyaK2MXovFylt7o%3D 10.1074/jbc.270.43.25348 7592697
9. C Addison T Daniel M Burdick H Liu J Ehlert Y Xue L Buechi A Walz A Richmond R Strieter 2000 The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ chemokine-induced angiogenic activity J Immunol 165 52669 52677
10. R Strieter P Polverini S Kunkel D Arenberg M Burdick J Kasper J Dzuiba J Van Damme A Walz D Marriott S Chan S Roczniak A Shanafelt 1995 The functional role of the ELR motif in CXC chemokine-mediated angiogensis J Biol Chem 270 27348 27357 1:CAS:528:DyaK2MXpsVGltbc%3D 10.1074/jbc.270.45.27348 7592998
11. F Ferrer L Miller R Andrawis S Kurtzman P Albertsen V Laudone D Kreutzer 1998 Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells Urology 51 161 167 1:STN:280:DyaK1c7hvVKguw%3D%3D 10.1016/S0090-4295(97)00491-3 9457313 (Pubitemid 28092530)
12. AB Lentsch 2002 The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white? FASEB J 16 9 1093 1095 1:CAS:528:DC%2BD38XltlKhs7g%3D 10.1096/fj.02-0066hyp 12087071 (Pubitemid 34753516)
13. L Xu A Ashkenazi A Chaudhuri 2007 Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells Angiogenesis 10 4 307 318 1:CAS:528:DC%2BD2sXht1ClurvE 10.1007/s10456-007-9084-y 17955335 (Pubitemid 350045887)
14. L Horton Y Yu S Zaja-Milatovic R Strieter A Richmond 2007 Opposing roles of murine Duffy antigen receptor for chemokines and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth Cancer Res 67 9791 9799 1:CAS:528:DC%2BD2sXhtFOnsbzL 10.1158/0008-5472.CAN-07-0246 17942909 (Pubitemid 47621226)
15. DJ Schaid SK McDonnell KE Zarfas JM Cunningham S Hebbring SN Thibodeau 2006 Pooled genome linkage scan of aggressive prostate cancer: results from the international consortium for prostate cancer genetics Hum Genet 120 471 485 10.1007/s00439-006-0219-9 16932970 (Pubitemid 44669782)
16. M Olsson C Hansson N Avent I Akesson C Green G Daniels 1998 A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers Transfusion 38 168 173 1:STN:280:DyaK1c7ptlSquw%3D%3D 10.1046/j.1537-2995.1998. 38298193099.x 9531948
17. M Hessner R Pircon S Johnson R Luhm 1999 Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reaction Prenat Diagn 19 41 45 1:CAS:528:DyaK1MXhsleiuro%3D 10073905
18. A Cross U Peters V Kirsh G Andriole D Reding R Hayes R Sinha 2005 A prospective study of meat and meat mutagens and prostate cancer risk Cancer Res 65 11779 11784 1:CAS:528:DC%2BD2MXhtlWiu7jP 10.1158/0008-5472.CAN-05-2191 16357191 (Pubitemid 41821740)
19. S Peiper Z Wang K Neote A Martin H Showell M Conklyn K Ogborne T Hadley Z Lu J Hesselgesser R Horuk 1995 The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor J Exp Med 181 1311 1317 1:CAS:528:DyaK2MXkslWntro%3D 10.1084/jem.181.4.1311 7699323